WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002008198) NOVEL IMIDAZOLIDINONES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/008198    International Application No.:    PCT/US2001/022828
Publication Date: 31.01.2002 International Filing Date: 19.07.2001
Chapter 2 Demand Filed:    23.01.2002    
IPC:
A61K 38/00 (2006.01), C07D 233/38 (2006.01), C07K 5/02 (2006.01), C07K 7/02 (2006.01)
Applicants: SCHERING CORPORATION [US/US]; 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 (US)
Inventors: ARASAPPAN, Ashok; (US).
PAREKH, Tejal; (US).
NJOROGE, F., George; (US).
GIRIJAVALLABHAN, Viyyoor, Moopil; (US).
GANGUILY, Ashit, K.; (US)
Agent: KALYANARAMAN, Palaiyur, S.; Schering Corporation Patent Department K-6-1 1990 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 (US)
Priority Data:
60/220,110 21.07.2000 US
Title (EN) NOVEL IMIDAZOLIDINONES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
(FR) NOUVEAUX IMIDAZOLIDINONES COMME INHIBITEURS DE LA PROTEASE NS3-SERINE DU VIRUS DE L'HEPATITE C
Abstract: front page image
(EN)The present invention discloses novel imidazolidinones which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such imidazolidinones as well as methods of using them to treat disorders associated with the HCV protease.
(FR)L'invention concerne de nouveaux imidazolidinones présentant une activité inhibitrice de la protéase HCV ainsi que des procédés de fabrication de ces composants. Selon un autre mode de réalisation, des préparations pharmaceutiques contenant lesdits imidazolidinones et des procédés d'utilisation de ces préparations sont proposés en vue de traiter les troubles associés à la protéase HCV.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, HR, HU, ID, IL, IN, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LU, LV, MA, MD, MG, MK, MN, MX, MZ, NO, NZ, PL, PT, RO, RU, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UZ, VN, YU, ZA.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)